Ameluz-photodynamic therapy in superficial basal cell carcinoma may improve the clearance of target lesions, as shown in ...

Cipla share price had fallen after the company's September quarter results as analysts cut their target price, citing weaker than expected domestic business and challenges in its key products.

The clearance of Cipla's Goa facility opens the doors for the launch of Abraxane, which could be a around $120 million opportunity at peak.

Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off.

Find insight on Domain, Sensata Technologies and more in the latest Market Talks covering Technology, Media and Telecom.

Cliftonville make it three successive Irish Premiership wins as they edged rivals Crusaders 1-0 in an entertaining game at ...

Leading drug maker Cipla shares today saw a steep rally of 10% after the USFDA classified its Goa facility as a Voluntary ...

Adams said he believed it was unlikely that Kennedy could be appointed to lead a major health agency because he has no medical expertise, it would likely be difficult for him to pass a background ...

Multiple players are exploring whether modalities designed to combat B cell malignancies can be repurposed against lupus, myasthenia gravis and other conditions traced to misdirected immune response.

With their innovative technology ASX medical imaging companies are capitalising on billions of dollars in contracts annually being awarded to companies by the US Department of Veterans Affairs.

Chelsea and Manchester United continued their undefeated starts in WSL while Tottenham won via a late, and bizarre, own goal ...

Orrick's Founder Series offers monthly top tips for UK startups on key considerations at each stage of their lifecycle, from incorporating a ...